Tiziana Life Sciences Ltd
Clinical trials sponsored by Tiziana Life Sciences Ltd, explained in plain language.
-
Nasal spray could slow brain damage in progressive MS
Disease control Recruiting nowThis study tests a nasal spray called foralumab in people with non-active secondary progressive multiple sclerosis (SPMS), a form of MS that worsens over time. The goal is to see if the drug can reduce brain inflammation and slow disability without serious side effects. About 54 …
Phase: PHASE2 • Sponsor: Tiziana Life Sciences LTD • Aim: Disease control
Last updated May 26, 2026 12:00 UTC
-
Nasal spray could tame brain inflammation in rare neurological disease
Disease control Recruiting nowThis early study tests a nasal spray called foralumab in 5 adults with Multiple System Atrophy (MSA), a rare brain disease that gets worse over time. The goal is to see if the drug can calm overactive immune cells in the brain and slow down the disease. Participants will be monit…
Phase: PHASE2 • Sponsor: Tiziana Life Sciences LTD • Aim: Disease control
Last updated May 11, 2026 20:38 UTC